Good afternoon :)
Place Order
Add to Watchlist

Kilitch Drugs (India) Ltd

KILITCH

Kilitch Drugs (India) Ltd

KILITCH
Health CarePharmaceuticals
SmallcapWith a market cap of ₹561 cr, stock is ranked 1,612
High RiskStock is 4.38x as volatile as Nifty
350.900.46% (+1.60)
350.900.46% (+1.60)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹561 cr, stock is ranked 1,612
High RiskStock is 4.38x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹561 cr, stock is ranked 1,612
High RiskStock is 4.38x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
38.533.73
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.765.900.56%

Forecast & Ratings

Detailed Forecast 
100%
Analysts have suggested that investors can buy this stock

from 1 analyst

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Kilitch Drugs (India) Limited is engaged in the development and operations of pharmaceutical business. The Company's services range from manufacturing to marketing a host of formulations in solid, liquid and parenteral forms.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 21.47%, vs industry avg of 8.36%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.03% to 0.04%

Higher than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 15.22%, vs industry avg of 9.82%

Loading...

Financial YearFY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023TTM
Total Revenue21.7523.7729.7953.8986.4957.4571.19117.14142.52160.06
Raw Materialssubtract6.498.9210.5026.4448.3529.8236.2265.4874.53131.73
Power & Fuel Costsubtract0.820.971.061.111.421.621.572.252.15
Employee Costsubtract3.133.473.384.305.285.695.246.1811.73
Selling & Administrative Expensessubtract4.425.176.988.1912.5611.5011.1717.8823.53
Operating & Other expensessubtract5.946.767.275.287.604.289.0111.949.93
Depreciation/Amortizationsubtract1.8510.059.762.042.052.001.992.473.553.25
Interest & Other Itemssubtract0.050.060.160.420.650.940.881.335.085.82
Taxes & Other Itemssubtract-0.66-0.44-0.430.964.760.771.362.251.564.68
EPS-0.22-8.46-6.723.822.630.542.424.746.719.36
DPS0.000.000.000.500.500.000.000.000.000.00
Payout ratio0.000.000.000.130.190.000.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Kilitch Drugs (India) Ltd53.713.73
Sun Pharmaceutical Industries Ltd43.546.220.75%
Cipla Ltd39.634.680.62%
Dr Reddy's Laboratories Ltd22.354.330.66%

Price Comparison

Compare KILITCH with any stock or ETF
Compare KILITCH with any stock or ETF
KILITCH
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding69.23%0.00%0.00%0.00%30.77%

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Shareholding History

Dec '22MarJunSepDec '23Mar0.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateSep 20, 2019

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Sep 20, 2019

Cash Dividend

Ex DateEx DateSep 18, 2018

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Sep 18, 2018

Cash Dividend

Ex DateEx DateSep 24, 2012

Special
Special | Div/Share: ₹30.00

Dividend/Share

30.00

Ex DateEx Date

Sep 24, 2012

Cash Dividend

Ex DateEx DateAug 18, 2011

Final
Final | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Aug 18, 2011

Cash Dividend

Ex DateEx DateOct 14, 2010

Final
Final | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Oct 14, 2010